Sarah Haylock‐Jacobs

1.6k total citations · 1 hit paper
20 papers, 1.2k citations indexed

About

Sarah Haylock‐Jacobs is a scholar working on Epidemiology, Hepatology and Oncology. According to data from OpenAlex, Sarah Haylock‐Jacobs has authored 20 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 7 papers in Hepatology and 6 papers in Oncology. Recurrent topics in Sarah Haylock‐Jacobs's work include Hepatitis B Virus Studies (7 papers), Hepatitis C virus research (7 papers) and T-cell and B-cell Immunology (5 papers). Sarah Haylock‐Jacobs is often cited by papers focused on Hepatitis B Virus Studies (7 papers), Hepatitis C virus research (7 papers) and T-cell and B-cell Immunology (5 papers). Sarah Haylock‐Jacobs collaborates with scholars based in Canada, Australia and United Kingdom. Sarah Haylock‐Jacobs's co-authors include V. Wee Yong, Lorraine Lau, Michael B. Keough, Shaun R. McColl, Iain Comerford, Scott L. Townley, David P. Stirling, Mark D. Bunting, Axinia Döring and Scott Sloka and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Nature reviews. Neuroscience.

In The Last Decade

Sarah Haylock‐Jacobs

19 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pathophysiology of the brain extracellular matrix: a new target for remyelination

2013 413 citations Lorraine Lau, Michael B. Keough et al. Nature reviews. Neuroscience profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sarah Haylock‐Jacobs Canada	12	369	366	257	224	197	20	1.2k
Gail Workman United States	18	231 0.6×	574 1.6×	221 0.9×	270 1.2×	158 0.8×	25	1.5k
Michael J. Hansen United States	15	381 1.0×	810 2.2×	240 0.9×	396 1.8×	130 0.7×	46	1.8k
Tomoko Nakanishi Japan	4	353 1.0×	1.3k 3.5×	215 0.8×	331 1.5×	303 1.5×	9	2.5k
Bushra Zaidi United States	10	274 0.7×	499 1.4×	222 0.9×	208 0.9×	494 2.5×	18	1.3k
Rainer Probstmeier Germany	28	450 1.2×	995 2.7×	181 0.7×	496 2.2×	306 1.6×	60	2.0k
Kristen M. Smith United States	19	247 0.7×	910 2.5×	367 1.4×	138 0.6×	131 0.7×	34	1.9k
Nicole Dünker Germany	20	121 0.3×	944 2.6×	237 0.9×	252 1.1×	114 0.6×	60	1.8k
Claudia X. Dominguez United States	12	724 2.0×	660 1.8×	650 2.5×	208 0.9×	134 0.7×	18	1.8k
Ellen Iacobaeus Sweden	17	443 1.2×	268 0.7×	381 1.5×	62 0.3×	95 0.5×	32	1.5k
Franz-Josef Müeller United States	9	177 0.5×	731 2.0×	210 0.8×	422 1.9×	790 4.0×	9	1.7k

Countries citing papers authored by Sarah Haylock‐Jacobs

Since Specialization

Citations

This map shows the geographic impact of Sarah Haylock‐Jacobs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Haylock‐Jacobs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Haylock‐Jacobs more than expected).

Fields of papers citing papers by Sarah Haylock‐Jacobs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Haylock‐Jacobs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Haylock‐Jacobs. The network helps show where Sarah Haylock‐Jacobs may publish in the future.

Co-authorship network of co-authors of Sarah Haylock‐Jacobs

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Haylock‐Jacobs. A scholar is included among the top collaborators of Sarah Haylock‐Jacobs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Haylock‐Jacobs. Sarah Haylock‐Jacobs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bryant, Robert V., Sarah Haylock‐Jacobs, Alice S. Day, et al.. (2025). Faecal microbiota transplant in Parkinson’s disease: pilot study to establish safety & tolerability. npj Parkinson s Disease. 11(1). 203–203. 3 indexed citations

Costello, Samuel P., Robert V. Bryant, Sarah Haylock‐Jacobs, et al.. (2025). A study protocol for a double-blinded, randomised, placebo-controlled trial on the use of encapsulated FMT for reducing the side effects of HSCT: the HSCT-BIOME study. BMC Cancer. 25(1). 656–656.

Tucker, Emily, et al.. (2023). Stool donor screening within a Therapeutic Goods Administration compliant donor screening program for fecal microbiota transplantation. JGH Open. 7(3). 172–177. 9 indexed citations

Congly, Stephen E., et al.. (2023). A real-world retrospective single-centre study of the cost-effectiveness and long-term outcomes of pegylated interferon for chronic hepatitis B. PubMed. 6(3). 305–313. 1 indexed citations

Osiowy, Carla, Sarah Haylock‐Jacobs, Scott Fung, et al.. (2022). Molecular epidemiology and clinical characteristics of hepatitis D virus infection in Canada. JHEP Reports. 4(5). 100461–100461. 16 indexed citations

Coffin, Carla S., Scott Fung, Alexander Wong, et al.. (2022). Brief Report: Effect of Antiretroviral Switch From Tenofovir Disoproxil fumarate to Tenofovir Alafenamide on Alanine Aminotransferase, Lipid Profiles, and Renal Function in HIV/HBV-Coinfected Individuals in a Nationwide Canadian Study. JAIDS Journal of Acquired Immune Deficiency Syndromes. 91(4). 368–372. 6 indexed citations

Ko, Hin Hin, Sarah Haylock‐Jacobs, Karen Doucette, et al.. (2022). Severe Hepatic Steatosis Is Associated With Low-Level Viremia and Advanced Fibrosis in Patients With Chronic Hepatitis B in North America. SHILAP Revista de lepidopterología. 1(1). 106–116. 3 indexed citations

Ramji, Alnoor, Karen Doucette, Curtis Cooper, et al.. (2022). Nationwide retrospective study of hepatitis B virological response and liver stiffness improvement in 465 patients on nucleos(t)ide analogue. World Journal of Gastroenterology. 28(31). 4390–4398. 4 indexed citations

Farag, Mina, Scott Fung, Edward Tam, et al.. (2021). Effectiveness and Renal Safety of Tenofovir Alafenamide Fumarate among Chronic Hepatitis B Patients: Real‐World Study. Journal of Viral Hepatitis. 28(6). 942–950. 18 indexed citations

10.

Cooper, Curtis, David Wong, Sarah Haylock‐Jacobs, et al.. (2020). Distinct Hepatitis B and HIV co‐infected populations in Canada. Journal of Viral Hepatitis. 28(3). 517–527. 1 indexed citations

11.

Lau, Lorraine, et al.. (2013). Pathophysiology of the brain extracellular matrix: a new target for remyelination. Nature reviews. Neuroscience. 14(10). 722–729. 413 indexed citations breakdown →

12.

Lau, Lorraine, Michael B. Keough, Sarah Haylock‐Jacobs, et al.. (2012). Chondroitin sulfate proteoglycans in demyelinated lesions impair remyelination. Annals of Neurology. 72(3). 419–432. 203 indexed citations

13.

Nathoo, Nabeela, Smriti Agrawal, Sarah Haylock‐Jacobs, et al.. (2012). Susceptibility-weighted imaging in the experimental autoimmune encephalomyelitis model of multiple sclerosis indicates elevated deoxyhemoglobin, iron deposition and demyelination. Multiple Sclerosis Journal. 19(6). 721–731. 34 indexed citations

14.

Haylock‐Jacobs, Sarah, Michael B. Keough, Lorraine Lau, & V. Wee Yong. (2011). Chondroitin sulphate proteoglycans: Extracellular matrix proteins that regulate immunity of the central nervous system. Autoimmunity Reviews. 10(12). 766–772. 48 indexed citations

15.

Haylock‐Jacobs, Sarah, Iain Comerford, Mark D. Bunting, et al.. (2011). PI3Kδ drives the pathogenesis of experimental autoimmune encephalomyelitis by inhibiting effector T cell apoptosis and promoting Th17 differentiation. Journal of Autoimmunity. 36(3-4). 278–287. 65 indexed citations

16.

Klingler‐Hoffmann, Manuela, Sarah Haylock‐Jacobs, Yuka Harata‐Lee, et al.. (2011). Differential roles for the p101 and p84 regulatory subunits of PI3Kγ in tumor growth and metastasis. Oncogene. 31(18). 2350–2361. 45 indexed citations

17.

Comerford, Iain, Robert J. B. Nibbs, W. Reid Litchfield, et al.. (2010). The atypical chemokine receptor CCX-CKR scavenges homeostatic chemokines in circulation and tissues and suppresses Th17 responses. Blood. 116(20). 4130–4140. 63 indexed citations

18.

Comerford, Iain, Mark D. Bunting, Kevin Fenix, et al.. (2010). An immune paradox: How can the same chemokine axis regulate both immune tolerance and activation?. BioEssays. 32(12). 1067–1076. 103 indexed citations

19.

Liston, Adrian, Rachel E. Kohler, Scott L. Townley, et al.. (2009). Inhibition of CCR6 Function Reduces the Severity of Experimental Autoimmune Encephalomyelitis via Effects on the Priming Phase of the Immune Response. The Journal of Immunology. 182(5). 3121–3130. 106 indexed citations

20.

Kohler, Rachel E., Iain Comerford, Scott L. Townley, et al.. (2008). Antagonism of the Chemokine Receptors CXCR3 and CXCR4 Reduces the Pathology of Experimental Autoimmune Encephalomyelitis. Brain Pathology. 18(4). 504–516. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact